its a stupid call when a company is 50% dependent on some other company's success
Actually this is an Excellent call since the risk of operating expenses such as R&D, payroll and all others are out of the picture.Income goes right to the bottom line as if it is a royalty (no risk).Better than if they had to sell the drug themselves.
Absolutely, pure profit!
You must be sore loserman. LOL!